JOSHUA LEDERBERG (Chair), Sackler Foundation Scholar, The Rockefeller University, New York, New York
VINCENT I. AHONKHAI, Vice President and Director, Anti-Infectives and Biologicals, SmithKline Beecham Corporation, Collegeville, Pennsylvania
STEVEN J. BRICKNER, Manager of Medicinal Chemistry, Central Research Division, Pfizer, Inc., Groton, Connecticut
GAIL H. CASSELL, Vice President for Infectious Diseases Research, Drug Discovery Research, and Clinical Investigation, Eli Lilly & Company, Indianapolis, Indiana
GARY CHRISTOPHERSON, Principal Deputy Assistant Secretary for Health Affairs and Senior Advisor for Force Health Protection, U.S. Department of Defense Reserve Affairs, Washington, D.C.
GORDON H. DeFRIESE, Director and Professor of Social Medicine, Epidemiology, Health Policy, and Administration, Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina
CEDRIC E. DUMONT, Medical Director, Office of Medical Services, U.S. Department of State, Washington, D.C.
JESSE GOODMAN, Acting Deputy Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Washington, D.C.
RENU GUPTA, Head of U.S. Research and Development, and Head of Global Cardiovascular, Metabolic, and Endocrine G.I Disorders, Novartis Pharmaceuticals, East Hanover, New Jersey
MARGARET A. HAMBURG, Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Washington, D.C.
CAROLE A. HEILMAN, Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
JAMES M. HUGHES, Assistant Surgeon General, and Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
SAMUEL L. KATZ, Wilburt C. Davison Professor, Department of Pediatrics, Duke University Medical Center; Undersecretary for Health, Veterans Health Administration, U.S. Department of Veterans Affairs, Washington, D.C.
MARCELLE LAYTON, Bureau of Communicable Diseases, New York City Department of Health, New York, New York
CARLOS LOPEZ, Research Fellow, Research Acquisitions, Eli Lilly Research Laboratories, Indianapolis, Indiana
STEPHEN S. MORSE, Professor of Epidemiology, Columbia University School of Public Health, New York, New York
MICHAEL T. OSTERHOLM, Chairman and Chief Executive Officer, Infectious Control Advisory Network, Eden Prairie, Minnesota
MARC RUBIN, Vice President of Infectious Diseases Therapeutic Development Group, Glaxo Wellcome, Research Triangle Park, North Carolina
DAVID M. SHLAES, Vice President, Infectious Disease Research, Wyeth-Ayerst Research, Pearl River, New York.
JANET SHOEMAKER, Director, Public Affairs, American Society for Microbiology, Washington, D.C.
JOHN D. SIEGFRIED, Deputy Vice-President, Science and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America, Washington, D.C.
P. FREDERICK SPARLING, Chair of Medicine, University of North Carolina at Chapel Hill, and President, Infectious Diseases Society of America, Washington, D.C.
C. DOUGLAS WEBB, JR., Senior Medical Director, Infectious Diseases Global Marketing, Bristol-Myers Squibb, Princeton, New Jersey
CATHERINE E. WOTEKI, Undersecretary for Food and Safety, U.S. Department of Agriculture, Washington, D.C.
Liaisons to the Forum
ENRIQUETA C. BOND, President, Burroughs Wellcome Fund, Morrisville, North Carolina
NANCY CARTER-FOSTER, Director, Program for Emerging Infections and HIV/AIDS, U.S. Department of State, Washington, D.C.
PATRICK W. KELLEY, Colonel, U.S. Army, and Director, Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, D.C.
EDWARD MCSWEEGAN, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
STEPHEN M. OSTROFF, Acting Deputy Director, and Associate Director for Epidemiologic Science, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
GARY ROSELLE, Program Director for Infectious Disease, Veterans Health Administration, U.S. Department of Veterans Affairs, Cincinnati, Ohio
JAMES M. SIGG, Contract Liaison Officer, Office of Management and Contracts, Centers for Biologics Evaluation and Research, U.S. Food and Drug Administration, Washington, D.C.
FRED TENOVER, Chief, Nosocomial Pathogens Laboratory Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
KAYE WACHSMUTH, Deputy Administrator, Office of Public Health and Science, Food Safety Inspection Service, U.S. Department of Agriculture, Washington, D.C.
JONATHAN R. DAVIS, Senior Program Officer
VIVIAN P. NOLAN, Research Associate
NICOLE AMADO, Project Assistant
THELMA COX, Project Assistant
KATHI HANNA, Consultant
MICHAEL HAYES, Copy Editor
JUDITH R. BALE, Director, Board on Global Health
ANDREW M. POPE, Director, Board on Health Sciences Policy
SARAH PITLUCK, Research Assistant
ALDEN CHANG, Project Assistant
ANDREA L. COHEN, Financial Associate
CARLOS GABRIEL, Financial Associate
National Academies Press (US), Washington (DC)
Institute of Medicine (US) Forum on Emerging Infections; Davis JR, Lederberg J, editors. Emerging Infectious Diseases from the Global to the Local Perspective: A Summary of a Workshop of the Forum on Emerging Infections. Washington (DC): National Academies Press (US); 2001. FORUM ON EMERGING INFECTIONS.